The State of Science Funding

Should Sacramento, Albany, and Providence be taking over for Uncle Sam?

Written byGlenn McGee
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

In 2006 the budget for the National Institutes of Health was cut for the first time in 30 years. The rhetorical justification for cuts to areas such as cancer research is Orwellian: "Targeted" shifts in funding must be made to protect the people from imminent threats. So, after four years in the doldrums, smaller NIH coffers will be redistributed. Those who do not work on bioterrorism will be debited to pay those who do.

What does a fractional decrease in federal research money really mean for Joe Scientist? Plenty. Success rates for grants, says the American Association for the Advancement of Science, could dip more than 10% from 31% in 2001.

The shifts in funding are driven not only by economics but also by the most intense antiscience politics in decades. The same activists who would later expend more energy on an attempt to "save" a woman in persistent vegetative ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies